483 Acella Pharmaceuticals Mar 2019

483 Acella Pharmaceuticals Mar 2019

Vanessa Coulter FDA$119.00 - Available Now

FDA investigators audited the Acella Pharmaceuticals - Alpharetta, GA, United States facility and issued inspectional observations (via FDA 483) on 29 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Mar 2019
  • Location: Alpharetta, United States
  • FEI: 3006691461
Add To Cart